MOMI, Stefania
 Distribuzione geografica
Continente #
NA - Nord America 1.804
EU - Europa 1.342
AS - Asia 1.214
SA - Sud America 195
AF - Africa 17
Continente sconosciuto - Info sul continente non disponibili 2
OC - Oceania 1
Totale 4.575
Nazione #
US - Stati Uniti d'America 1.774
SG - Singapore 535
IE - Irlanda 271
UA - Ucraina 250
IT - Italia 207
CN - Cina 203
HK - Hong Kong 193
BR - Brasile 170
RU - Federazione Russa 155
VN - Vietnam 153
SE - Svezia 123
DE - Germania 99
FI - Finlandia 82
GB - Regno Unito 55
KR - Corea 39
FR - Francia 30
TR - Turchia 18
CA - Canada 16
IN - India 15
AR - Argentina 13
BD - Bangladesh 11
ES - Italia 10
BE - Belgio 9
AT - Austria 8
CH - Svizzera 8
JP - Giappone 7
NL - Olanda 7
UZ - Uzbekistan 7
ZA - Sudafrica 7
MX - Messico 6
PL - Polonia 6
IR - Iran 5
LB - Libano 5
CZ - Repubblica Ceca 4
EC - Ecuador 4
MA - Marocco 4
PK - Pakistan 4
ID - Indonesia 3
RO - Romania 3
VE - Venezuela 3
BG - Bulgaria 2
CL - Cile 2
CO - Colombia 2
DZ - Algeria 2
GR - Grecia 2
HU - Ungheria 2
IQ - Iraq 2
JO - Giordania 2
LT - Lituania 2
PH - Filippine 2
RS - Serbia 2
TT - Trinidad e Tobago 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AE - Emirati Arabi Uniti 1
AF - Afghanistan, Repubblica islamica di 1
AL - Albania 1
AU - Australia 1
AZ - Azerbaigian 1
BB - Barbados 1
CR - Costa Rica 1
DO - Repubblica Dominicana 1
EG - Egitto 1
EU - Europa 1
GT - Guatemala 1
IL - Israele 1
IS - Islanda 1
KE - Kenya 1
KZ - Kazakistan 1
LK - Sri Lanka 1
MK - Macedonia 1
MY - Malesia 1
MZ - Mozambico 1
NO - Norvegia 1
NP - Nepal 1
PA - Panama 1
PR - Porto Rico 1
PT - Portogallo 1
SN - Senegal 1
TH - Thailandia 1
TW - Taiwan 1
UY - Uruguay 1
Totale 4.575
Città #
Singapore 341
Chandler 326
Dublin 266
Hong Kong 193
San Mateo 146
Jacksonville 139
Dong Ket 83
Boardman 80
Perugia 78
Altamura 77
Santa Clara 75
Ashburn 71
Beijing 66
Medford 63
Princeton 63
Lawrence 57
Ann Arbor 51
Wilmington 51
Moscow 40
Seoul 39
Andover 29
Ho Chi Minh City 28
New York 28
Des Moines 27
Munich 27
Los Angeles 22
Saint Petersburg 21
São Paulo 21
Helsinki 18
Dearborn 17
Piscataway 17
Hanoi 16
The Dalles 14
Frankfurt am Main 12
San Paolo di Civitate 12
Woodbridge 12
Izmir 11
Dallas 10
Turku 10
Brooklyn 9
Brussels 9
London 9
Norwalk 9
Falkenstein 8
Shanghai 7
Stockholm 7
Tokyo 7
Ankara 6
Denver 6
Johannesburg 6
San Francisco 6
Columbus 5
Curitiba 5
New Delhi 5
Poplar 5
Toronto 5
Amsterdam 4
Auburn Hills 4
Belo Horizonte 4
Campo Grande 4
Da Nang 4
Falls Church 4
Haiphong 4
Madrid 4
Montreal 4
Nuremberg 4
Olomouc 4
Orem 4
Ottawa 4
Phoenix 4
Roubaix 4
Santo André 4
Amelia 3
Charlotte 3
Chennai 3
Houston 3
Hải Dương 3
Menlo Park 3
Mexico City 3
Milan 3
Porto Alegre 3
Rio de Janeiro 3
Rome 3
Salvador 3
Southwark 3
Xinxiang 3
Zhengzhou 3
Amman 2
Aracaju 2
Atlanta 2
Baghdad 2
Brasília 2
Caraguatatuba 2
Chicago 2
Delhi 2
Espoo 2
Franca 2
Granarolo dell'Emilia e Viadagola 2
Guayaquil 2
Gubbio 2
Totale 2.906
Nome #
Loss of matrix metalloproteinase 2 in platelets reduces arterial thrombosis in vivo. 116
Interaction with damaged vessel wall in vivo in humans induces platelets to express CD40L resulting in endothelial activation. No effect of aspirin intake. 113
Nitric oxide and its antithrombotic action on the cardiovascular system 109
Platelets are essential for leukocyte recruitment in allergic inflammation. 106
RhoA signaling through platelet P2Y1 receptor controls leukocyte recruitment in allergic mice. 104
Contribution of matrix metalloproteinase 2 to joint destruction in group B Streptococcus-induced murine arthritis. 103
A novel mechanism regulating human platelet activation by MMP-2-mediated PAR1 biased signaling 99
A novel nitric oxide-releasing statin derivative exerts and antiplatelet/antithrombotic activity and inhibits tissue factor expression. 98
Alteration of Liver Enzymes Is a Feature of the Myh9-Related Disease Syndrome. 97
Allergen induces the migration of platelets to lung tissue in allergic asthma. 97
Activated human protein C prevents thrombin-induced thromboembolism in mice. Evidence that activated protein c reduces intravascular fibrin accumulation through the inhibition of additional thrombin generation. 94
Defective platelet beta-N-Acetyl hexosaminidase content and release in chronic myeloproliferative disorders 94
Platelet P-selectin is required for pulmonary eosinophil and lymphocyte recruitment in a murine model of allergic inflammation 92
Nitric oxide-donating aspirin (NCX 4016): an overview of its pharmacological properties and clinical perspectives. 90
Anti-platelet treatments in cancer: Basic and clinical research 90
Anti-platelet therapy: phosphodiesterase inhibitors. 89
Nitric oxide enhances the anti-inflammatory and anti-atherogenic activity of atorvastatin in a mouse model of accelerated atherosclerosis. 87
Mechanisms of thrombocytopenia in platelet-type von Willebrand disease 87
AB0952 Intra-articular low molecular weight hyaluronate reduces platelet influx and matrix metalloproteinase-2 levels in synovial fluid of patients with knee osteoarthritis 85
Matrix metalloproteinases and peripheral arterial disease. 84
Platelets contribute to the accumulation of matrix metalloproteinase type 2 in synovial fluid in osteoarthritis 84
Established and new antiplatelet therapies 79
Matrix metalloproteinase-2 of human carotid atherosclerotic plaques promotes platelet activation. Correlation with ischaemic events. 79
Matrix metalloproteinase-2 enhances platelet deposition on collagen under flow conditions 79
A dichotomy in platelet activation: Evidence of different functional platelet responses to inflammatory versus haemostatic stimuli 79
Endothelium, venous thromboembolism and ischaemic cardiovascular events. 76
Platelets release matrix metalloproteinase-2 in the coronary circulation of patients with acute coronary syndromes: possible role in sustained platelet activation. 76
Chemotaxis and phagocytosis 76
Prevalence of hemostatic alterations in patients with recurrent spontaneous subconjunctival hemorrhage 76
A novel nitric oxide-releasing statin derivative exerts an antiplatelet/antithrombotic activity and inhibits tissue factor expression. 73
Platelet-targeted pharmacologic treatments as anti-cancer therapy 73
Prevention of pulmonary thromboembolism by NCX 4016, a nitric oxide-releasing aspirin. 72
Nitroaspirin plus clopidogrel versus aspirin plus clopidogrel against platelet thromboembolism and intimal thickening in mice 72
Highly Active Antiretroviral Therapy-related Mechanisms of Endothelial and Platelets Function Alterations 72
HYPERGLYCEMIA-INDUCED PLATELET ACTIVATION IN TYPE 2 DIABETES MELLITUS IS RESISTANT TO ASPIRIN BUT NOT TO A NITRIC OXIDE-DONATING AGENT. 72
Platelet and endothelial activation in catastrophic and quiescent antiphospholipid syndrome. 72
Resveratrol, at concentrations attainable with moderate wine consumption, stimulates human platelet nitric oxide production. 69
Platelet Priming. 68
Endogenous nitric oxide acts as a natural antithrombotic agent in vivo by inhibiting platelet aggregation in the pulmonary vasculature. 68
Pharmacologic profile and therapeutic potential of NCX 4016, a nitric oxide-releasing aspirin, for cardiovascular disorders. 67
Visualization of nitric oxide production by individual platelets during adhesion in flowing blood. 66
Low molecular weight heparins prevent thrombin-induced thromboembolism in mice despite low antithrombin activity. Evidence that the inhibition of feed-back activation of thrombin generation confers safety advantages over direct thrombin inhibition. 65
Reperfusion of cerebral artery thrombosis by the GPIb-VWF blockade with the Nanobody ALX-0081 reduces brain infarct size in guinea pigs. 64
Nitric oxide-enhancing or -releasing agents as antithrombotic drugs. 64
Impaired thrombin-induced platelet activation and thrombus formation in mice lacking the Ca(2+)-dependent tyrosine kinase Pyk2. 62
Platelets in respiratory disorders and inflammatory conditions. 61
Patients with primary antiphospholipid antibody syndrome and without associated vascular risk factors present a normal endothelial function. 61
Involvement of platelets in experimental mouse trypanosomiasis: evidence of mouse platelet cytotoxicity against Trypanosoma equiperdum. 61
Trombocitopenia da eparina nel paziente dializzato 60
NCX4016: a novel antithrombotic agent. 58
Potentiation and priming of platelet activation: a potential target for antiplatelet therapy. 57
Matrix Metalloproteinases and Platelet Function 55
Matrix metalloproteinase-2 on activated platelets triggers endothelial PAR-1 initiating atherosclerosis 54
NCX 6560, a nitric oxide-releasing derivative of atorvastatin, inhibits cholesterol biosynthesis and shows anti-inflammatory and anti-thrombotic properties. 53
Interactions of gallic acid, resveratrol, quercetin and aspirin at the platelet cyclooxygenase-1 level. Functional and modelling studies. 53
Platelets are necessary for airway wall remodeling in a murine model of chronic allergic inflammation. 52
Platelets and chemotaxis. 51
Role of Platelets in the Pathogenesis of Osteoarthritis and Biological Effects of Hyaluronic Acid: in Vivo and in Vitro Study 49
The effect of defibrotide on thromboembolism in the pulmonary vasculature of mice and rabbits and in the cerebral vasculature of rabbits 48
PCSK9 in Haemostasis and Thrombosis: Possible Pleiotropic Effects of PCSK9 Inhibitors in Cardiovascular Prevention 45
Platelet dysfunction in platelet-type von Willebrand disease due to the constitutive triggering of the Lyn-PECAM1 inhibitory pathway 45
Stroke prevention: from available antiplatelet drugs to novel molecular targets. 40
Stimulation of platelet nitric oxide production by nebivolol prevents thrombosis. 39
Dicer Neosynthesis Regulates Platelet Reactivity: A Mechanism Altered in Type 2 Diabetes 13
Totale 4.692
Categoria #
all - tutte 22.207
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 22.207


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021274 0 0 0 0 0 24 44 2 51 15 46 92
2021/2022507 12 110 12 26 9 10 7 147 7 19 69 79
2022/20231.002 70 232 10 71 78 104 0 48 338 3 30 18
2023/2024381 19 42 18 5 2 4 99 9 46 12 77 48
2024/2025768 6 78 34 28 107 37 29 56 157 32 142 62
2025/2026989 117 116 111 231 282 132 0 0 0 0 0 0
Totale 4.692